First Trust Direct Indexing L.P. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
First Trust Direct Indexing L.P. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$260,167
-21.7%
4,527
-48.9%
0.03%
-25.6%
Q1 2023$332,437
+28.1%
8,865
-4.3%
0.04%
+14.7%
Q4 2022$259,465
-6.7%
9,260
-6.3%
0.03%
-17.1%
Q3 2022$278,000
-19.0%
9,878
+0.3%
0.04%
-14.6%
Q2 2022$343,000
+0.3%
9,846
+3.3%
0.05%
+14.3%
Q1 2022$342,000
+53.4%
9,535
-0.3%
0.04%
+44.8%
Q4 2021$223,000
-7.5%
9,565
-20.0%
0.03%
-19.4%
Q2 2021$241,000
+10.6%
11,949
+0.3%
0.04%
-37.9%
Q1 2021$218,000
-6.4%
11,913
+2.8%
0.06%
-7.9%
Q4 2020$233,00011,5920.06%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders